Screening high-risk populations for lung cancer guideline recommendations

Journal of Thoracic Oncology

Volumn 8, Issue 10, 2013, Pages 1232-1237

  Roberts, Heidi ^a   Walker Dilks, Cindy ^b   Sivjee, Khalil ^c   Ung, Yee ^c   Yasufuku, Kazuhiro ^d   Hey, Amanda ^e   Lewis, Nancy ^f  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d TORONTO GENERAL HOSPITAL   (Canada)

^e Northeastern Regional Cancer Centre   (Canada)

^f CANCER CARE ONTARIO   (Canada)

Author keywords

Low dose computed tomography; Lung cancer; Screening

Indexed keywords

ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; EVIDENCE BASED PRACTICE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LUNG CANCER; ONCOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; THORAX RADIOGRAPHY;

AGED; AGED, 80 AND OVER; EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84892428542     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31829fd3d5     Document Type: Article

References (15)

1. Naidich DP, Marshall CH, Gribbin C, Arams RS, McCauley DI. Low-dose CT of the lungs: preliminary observations. Radiology 1990;175:729-731.
2. Kaneko M, Eguchi K, Ohmatsu H, et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996;201:798-802.
3. Mori K, Tominaga K, Hirose T, Sasagawa M, Yokoyama K, Moriyama N. Utility of low-dose helical CT as a second step after plain chest radiography for mass screening for lung cancer. J Thorac Imaging 1997;12:173-180.
4. Aberle DR, Adams AM, Berg CD, et al; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365(5):395-409.
5. Browman GP, Levine MN, Mohide EA, et al. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 1995;13:502-512.
6. Browman GP, Newman TE, Mohide EA, et al. Progress of clinical oncology guidelines development using the Practice Guidelines Development Cycle: the role of practitioner feedback. J Clin Oncol 1998;16:1226-1231.
7. Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012;307:2418-2429.
8. Canadian Cancer Society, National Cancer Institute of Canada. Canadian Cancer Statistics 2012. Toronto (Canada): National Cancer Institute of Canada, 2012.
9. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361: 2221-2229.
10. Cancer Care Ontario Disease Pathway Management Secretariat. Lung Cancer Diagnosis Pathway. Version 2012.2 [cited July 2012]. Available at: https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=124606 Accessed July 12, 2012.
11. Bellomi M, Veronesi G, Rampinelli C, et al. Evolution of lung nodules < or =5 mm detected with low-dose CT in asymptomaticsmokers. Br J Radiol 2007;80(957):708-712.
12. Henschke CI, Yankelevitz DF, Naidich DP, et al. CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology 2004;231:164-168.
13. Henschke CI, Yip R, Yankelevitz DF, Smith JP; International Early Lung Cancer Action Program Investigators. Definition of a positive test result in computed tomography screening for lung cancer: a cohort study. Ann Intern Med 2013;158:246-252.
14. Pastorino U, Rossi M, Rosato V, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 2012;21:308-315.
15. Wagnetz U, Menezes RJ, Boerner S, et al. CT screening for lung cancer: implication of lung biopsy recommendations. AJR Am J Roentgenol 2012;198:351-358.